Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver.

Harder J, Opitz OG, Brabender J, Olschewski M, Blum HE, Nomoto S, Usadel H.

Int J Cancer. 2008 Jun 15;122(12):2800-4. doi: 10.1002/ijc.23433.

2.

[Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].

Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):831-6. Chinese.

PMID:
19173828
3.

Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.

Su PF, Lee TC, Lin PJ, Lee PH, Jeng YM, Chen CH, Liang JD, Chiou LL, Huang GT, Lee HS.

Int J Cancer. 2007 Sep 15;121(6):1257-64.

4.

Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.

Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G.

Hepatology. 2002 Aug;36(2):427-32.

PMID:
12143052
5.

Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma.

Jain S, Chen S, Chang KC, Lin YJ, Hu CT, Boldbaatar B, Hamilton JP, Lin SY, Chang TT, Chen SH, Song W, Meltzer SJ, Block TM, Su YH.

PLoS One. 2012;7(4):e35789. doi: 10.1371/journal.pone.0035789. Epub 2012 Apr 20.

6.

Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

Yang B, Guo M, Herman JG, Clark DP.

Am J Pathol. 2003 Sep;163(3):1101-7.

7.

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH.

Am J Pathol. 2003 Oct;163(4):1371-8.

8.

RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.

Ara├║jo OC, Rosa AS, Fernandes A, Niel C, Villela-Nogueira CA, Pannain V, Araujo NM.

PLoS One. 2016 Apr 14;11(4):e0153796. doi: 10.1371/journal.pone.0153796. eCollection 2016.

9.

Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.

Formeister EJ, Tsuchiya M, Fujii H, Shpyleva S, Pogribny IP, Rusyn I.

Mutat Res. 2010 Oct 13;692(1-2):26-33. doi: 10.1016/j.mrfmmm.2010.07.013. Epub 2010 Aug 22.

10.

INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.

Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.

Oncogene. 2001 Oct 25;20(48):7104-9.

11.

Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus.

Kaneto H, Sasaki S, Yamamoto H, Itoh F, Toyota M, Suzuki H, Ozeki I, Iwata N, Ohmura T, Satoh T, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Omata M, Imai K.

Gut. 2001 Mar;48(3):372-7.

12.
13.

Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.

Di Gioia S, Bianchi P, Destro A, Grizzi F, Malesci A, Laghi L, Levrero M, Morabito A, Roncalli M.

BMC Cancer. 2006 Apr 10;6:89.

14.

CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.

Li B, Liu W, Wang L, Li M, Wang J, Huang L, Huang P, Yuan Y.

Ann Surg Oncol. 2010 Jul;17(7):1917-26. doi: 10.1245/s10434-010-0921-7. Epub 2010 Jan 29.

PMID:
20112070
15.

Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma.

Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S, Kanazumi N, Sugimoto H, Nakao A.

Br J Cancer. 2007 Nov 5;97(9):1260-5. Epub 2007 Oct 30.

16.

Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.

Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B, Dammann R.

Oncogene. 2003 Mar 27;22(12):1866-71.

PMID:
12660822
17.

Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis.

Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q, Zhu HG.

Exp Mol Pathol. 2010 Dec;89(3):268-75. doi: 10.1016/j.yexmp.2010.06.013. Epub 2010 Jul 8.

PMID:
20620135
18.

High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.

Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.

Mol Carcinog. 2002 Oct;35(2):85-92.

PMID:
12325038
19.

Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis.

Zhu YZ, Zhu R, Fan J, Pan Q, Li H, Chen Q, Zhu HG.

J Viral Hepat. 2010 Feb 1;17(2):98-107. doi: 10.1111/j.1365-2893.2009.01156.x. Epub 2009 Sep 2.

PMID:
19732323
20.

DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue.

Yasen M, Obulhasim G, Kajino K, Mogushi K, Mizushima H, Tanaka S, Tanaka H, Hino O, Arii S.

Int J Oncol. 2012 Mar;40(3):789-97. doi: 10.3892/ijo.2011.1282. Epub 2011 Dec 6.

PMID:
22159460

Supplemental Content

Support Center